CYP3A5 and ABCB1 variants predict treatment effect: Pharmacogenetics possibly useful when using sunitinib

Meta Diekstra, Henk Jan Guchelaar, Jesse Swen, Hans Gelderblom

Research output: Contribution to journal › Article › peer-review

Translated title of the contribution	Farmacogenetica mogelijk zinvol bij gebruik sunitinib
Original language	English
Pages (from-to)	20-21
Number of pages	2
Journal	Pharmaceutisch Weekblad
Volume	153
Issue number	7
Publication status	Published - 16 Feb 2018

Cite this

@article{60e59747f23646778e96c1efbfc551e9,

title = "CYP3A5 and ABCB1 variants predict treatment effect: Pharmacogenetics possibly useful when using sunitinib",

author = "Meta Diekstra and Guchelaar, \{Henk Jan\} and Jesse Swen and Hans Gelderblom",

year = "2018",

month = feb,

day = "16",

language = "English",

volume = "153",

pages = "20--21",

journal = "Pharmaceutisch Weekblad",

issn = "0031-6911",

publisher = "Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)",

number = "7",

}

TY - JOUR

T1 - CYP3A5 and ABCB1 variants predict treatment effect

T2 - Pharmacogenetics possibly useful when using sunitinib

AU - Diekstra, Meta

AU - Guchelaar, Henk Jan

AU - Swen, Jesse

AU - Gelderblom, Hans

PY - 2018/2/16

Y1 - 2018/2/16

UR - https://www.scopus.com/pages/publications/85044255637

M3 - Article

AN - SCOPUS:85044255637

SN - 0031-6911

VL - 153

SP - 20

EP - 21

JO - Pharmaceutisch Weekblad

JF - Pharmaceutisch Weekblad

IS - 7

ER -